Galimedix Therapeutics vs Upstream Bio
Galimedix Therapeutics vs Upstream Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Galimedix Therapeutics is on 37/100 and Upstream Bio on 61/100.
Where each one leads
Galimedix Therapeutics
Leads on none of the measures we hold for both companies.
Upstream Bio
- our overall score: 61/100 against 37/100
- agent readiness: 39/100 against 26/100
- domain rating: 32/100 against 27/100
- headcount: 75 against 12
- LinkedIn following: 11,799 against 1,022
At a glance
| Measure | Galimedix Therapeutics | Upstream Bio |
|---|---|---|
| What it is | Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Therapeutics, Alzheimers, Neuroscience | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Services |
| Founded | 2018 | 2021 |
| Headquarters | Copenhagen, Denmark | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Galimedix Therapeutics | Upstream Bio |
|---|---|---|
| Employees | 12 | 75 |
| Headcount growthLast 12 months | Not published | +43.4% |
| Total funding | Not published | $400M |
| Latest round | Not published | Series B |
| LinkedIn followers | 1,022 | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Galimedix Therapeutics | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 37/100 | 61/100 |
| Traction | 11/100 | 59/100 |
| Team | 60/100 | 70/100 |
| Search visibility | 24/100 | 37/100 |
| Quality | 45/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (26/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 27/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Galimedix Therapeutics | Upstream Bio |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Galimedix Therapeutics vs Upstream Bio: common questions
Which is better, Galimedix Therapeutics or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 37/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Galimedix Therapeutics and Upstream Bio compare on the numbers?
Upstream Bio leads on our overall score (61/100 against 37/100), agent readiness (39/100 against 26/100), domain rating (32/100 against 27/100), headcount (75 against 12), LinkedIn following (11,799 against 1,022).
Read the full Galimedix Therapeutics review and pricing or the Upstream Bio review and pricing. You can also browse other Galimedix Therapeutics alternatives we track.